Harmony Biosciences Holdings, Inc. Common Stock (HRMY) — Analysis Summary
Harmony Biosciences Holdings, Inc. Common Stock (HRMY) has a market cap of $1.98B with year-over-year revenue growth of +21.5%. Net margin stands at 18.3%. The stock trades at a P/E ratio of 13.6.
Key Takeaways
- Revenue changed +21.5% year-over-year
- Net margin of 18.3%
- P/E ratio of 13.6
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, HRMY posted revenue growth of +21.5% and trades at a P/E of 13.6.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.